Response to “CYP2C9 Polymorphism is Not a Major Determinant of Bosentan Exposure in Healthy Volunteers”
2013 ◽
Vol 95
(3)
◽
pp. 252-252
◽
2013 ◽
Vol 95
(3)
◽
pp. 250-251
◽
2010 ◽
Vol 39
(1-3)
◽
pp. 82-89
◽
2005 ◽
Vol 25
(1_suppl)
◽
pp. S673-S673
Keyword(s):